WallStreetZenWallStreetZen

NASDAQ: ACHV
Achieve Life Sciences Inc Stock Ownership - Who owns Achieve Life Sciences?

Insider buying vs selling

Have Achieve Life Sciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jerry WanPrincipal Accounting Officer2022-08-16266$4.37
$1.16kSell
John BencichCEO2022-08-163,059$4.37
$13.37kBuy
Cindy JacobsPresident & CMO2022-08-161,817$4.37
$7.94kBuy
Jerry WanPrincipal Accounting Officer2022-08-162,827$4.37
$12.35kBuy
John BencichCEO2022-04-281,827$7.43
$13.57kSell
Richard Alistair StewartExecutive Chairman2022-04-282,250$7.43
$16.72kSell
Jerry WanPrincipal Accounting Officer2022-04-28669$7.43
$4.97kSell
Anthony ClarkeCSO2022-04-28250$7.43
$1.86kSell
Cindy JacobsPresident & CMO2022-04-28609$7.43
$4.52kSell

1 of 1

ACHV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACHV insiders and whales buy or sell their stock.

ACHV Shareholders

What type of owners hold Achieve Life Sciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Dialectic Capital Management LP19.79%3,549,000$24.13MInsider
Robert Schacter10.19%1,827,426$12.43MInsider
Armistice Capital LLC8.89%1,593,188$10.83MInsider
Ventures West Capital Ltd5.40%968,582$6.59MInsider
Hig Oncogenex Inc3.04%545,512$3.71MInsider
Anthony Clarke3.04%545,138$3.71MInsider
Vanguard Group Inc1.90%340,238$2.31MInstitution
Shay Capital LLC1.90%340,000$2.31MInstitution
Long Focus Capital Management LLC1.75%313,220$2.13MInstitution
Perkins Capital Management Inc1.22%218,100$1.48MInstitution

1 of 3

ACHV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACHV11.15%52.34%Net Buying
OCS61.62%0.00%
ESPR65.80%34.20%Net SellingNet Selling
BCLI9.44%90.56%
NBTX9.93%0.00%

Achieve Life Sciences Stock Ownership FAQ

Who owns Achieve Life Sciences?

Achieve Life Sciences (NASDAQ: ACHV) is owned by 11.15% institutional shareholders, 52.34% Achieve Life Sciences insiders, and 36.51% retail investors. Dialectic Capital Management LP is the largest individual Achieve Life Sciences shareholder, owning 3.55M shares representing 19.79% of the company. Dialectic Capital Management LP's Achieve Life Sciences shares are currently valued at $24.13M.

If you're new to stock investing, here's how to buy Achieve Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.